Leerink Partnrs Issues Positive Forecast for TNDM Earnings
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) – Equities research analysts at Leerink Partnrs boosted their Q1 2025 EPS estimates for Tandem Diabetes Care in a report released on Thursday, February 27th. Leerink Partnrs analyst M. Kratky now anticipates that the medical device company will earn ($0.56) per share for the quarter, up from […]
